{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T19:19:09Z","timestamp":1762543149611,"version":"3.37.3"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,1,11]],"date-time":"2020-01-11T00:00:00Z","timestamp":1578700800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,11]],"date-time":"2020-01-11T00:00:00Z","timestamp":1578700800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Doc Ophthalmol"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1007\/s10633-019-09744-0","type":"journal-article","created":{"date-parts":[[2020,1,11]],"date-time":"2020-01-11T15:02:50Z","timestamp":1578754970000},"page":"1-14","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Electrophysiological and SD-OCT findings in patients receiving chloroquine therapy in relation to cumulative dosage and duration of treatment"],"prefix":"10.1007","volume":"141","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9526-9472","authenticated-orcid":false,"given":"Federica","family":"Bertoli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maja","family":"\u0160u\u0161tar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Jarc Vidmar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darko","family":"Perov\u0161ek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jelka","family":"Brecelj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u0160pela","family":"Markelj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Polona","family":"Jaki Mekjavi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Da\u0161a","family":"\u0160uput","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matija","family":"Tom\u0161i\u010d","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miriam","family":"Isola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudio","family":"Battistella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Lanzetta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marko","family":"Hawlina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,1,11]]},"reference":[{"key":"9744_CR1","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/292357","author":"RS Allam","year":"2015","unstructured":"Allam RS, Abd-Elmohsen MN, Khafagy MM et al (2015) Spectral-domain optical coherence tomography of preclinical chloroquine maculopathy in Egyptian rheumatoid arthritis patients. J Ophthalmol. https:\/\/doi.org\/10.1155\/2015\/292357","journal-title":"J Ophthalmol"},{"key":"9744_CR2","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1001\/jamaophthalmol.2014.1099","volume":"132","author":"MF Marmor","year":"2014","unstructured":"Marmor MF, Hu J (2014) Effect of disease stage on progression of hydroxychloroquine retinopathy. JAMA Ophthalmol 132:1105\u20131112","journal-title":"JAMA Ophthalmol"},{"key":"9744_CR3","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1136\/bjophthalmol-2013-303897","volume":"98","author":"S Kellner","year":"2014","unstructured":"Kellner S, Weinitz S, Farmand G, Kellner U (2014) Cystoid macular oedema and epiretinal membrane formation during progression of chloroquine retinopathy after drug cessation. Br J Ophthalmol 98:200\u2013206","journal-title":"Br J Ophthalmol"},{"key":"9744_CR4","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1016\/j.ophtha.2016.01.058","volume":"123","author":"MF Marmor","year":"2016","unstructured":"Marmor MF, Kellner U, Lai TY et al (2016) Recommendations on screening for chloroquine and hydroxychloroquine retinopathy (2016 revision). Ophthalmology 123:1386\u20131394","journal-title":"Ophthalmology"},{"key":"9744_CR5","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s10633-006-9006-0","volume":"112","author":"TYY Lai","year":"2006","unstructured":"Lai TYY, Ngai JWS, Wai-Man C, Lam DSC (2006) Visual field and multifocal electroretinography and their correlations in patients on hydroxychloroquine therapy. Doc Ophthalmol 112:177\u2013187","journal-title":"Doc Ophthalmol"},{"key":"9744_CR6","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s10633-008-9130-0","volume":"118","author":"JS Lyons","year":"2009","unstructured":"Lyons JS, Severns ML (2009) Using multifocal ERG ring ratios to detect and follow Plaquenil retinal toxicity: a review. Doc Ophthalmol 118:29\u201336","journal-title":"Doc Ophthalmol"},{"key":"9744_CR7","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/j.ophtha.2013.12.002","volume":"121","author":"MF Marmor","year":"2014","unstructured":"Marmor MF, Melles RB (2014) Disparity between visual fields and optical coherence tomography in hydroxychloroquine retinopathy. Ophthalmology 121:1257\u20131262","journal-title":"Ophthalmology"},{"key":"9744_CR8","unstructured":"Rahimy E, Vander J (2014) Multimodal imaging in Plaquenil toxicity. Rev Ophthalmol. https:\/\/www.reviewofophthalmology.com\/article\/multimodal-imaging-in-plaquenil-toxicity. Accessed 6 Aug 2014"},{"key":"9744_CR9","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1001\/archophthalmol.2011.371","volume":"130","author":"MF Marmor","year":"2012","unstructured":"Marmor MF (2012) Comparison of screening procedures in hydroxychloroquine toxicity. Arch Ophthalmol 130:461\u2013469","journal-title":"Arch Ophthalmol"},{"key":"9744_CR10","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/BF00156014","volume":"81","author":"M Hawlina","year":"1992","unstructured":"Hawlina M, Konec B (1992) New non corneal HK-loop electrode for clinical electroretinography. Doc Ophthalmol 81:253\u2013259","journal-title":"Doc Ophthalmol"},{"key":"9744_CR11","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1136\/bjo.58.8.709","volume":"58","author":"N Drasdo","year":"1974","unstructured":"Drasdo N, Fowler CW (1974) Non-linear projection of the retinal image in a wide-angle schematic eye. Br J Ophthalmol 58:709\u2013714","journal-title":"Br J Ophthalmol"},{"key":"9744_CR12","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1007\/s004170050016","volume":"238","author":"U Kellner","year":"2000","unstructured":"Kellner U, Kraus H, Foerster MH (2000) Multifocal ERG in chloroquine retinopathy: regional variance of retinal dysfunction. Graefes Arch Clin Exp Ophthalmol 238:94\u201397","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"9744_CR13","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s10633-007-9105-6","volume":"116","author":"U Kellner","year":"2008","unstructured":"Kellner U, Kellner S, Weinit S (2008) Chloroquine retinopathy: lipofuscin- and melanin-related fundus autofluorescence, optical coherence tomography and multifocal electroretinography. Doc Ophthalmol 116:119\u2013127","journal-title":"Doc Ophthalmol"},{"key":"9744_CR14","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1001\/archopht.122.7.973","volume":"122","author":"RK Maturi","year":"2004","unstructured":"Maturi RK, Yu M, Weleber RG (2004) Multifocal electroretinographic evaluation of long-term hydroxychloroquine users. Arch Ophthalmol 122:973\u2013981","journal-title":"Arch Ophthalmol"},{"key":"9744_CR15","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.ophtha.2014.07.018","volume":"122","author":"RB Melles","year":"2015","unstructured":"Melles RB, Marmor MF (2015) Pericentral retinopathy and racial differences in hydroxychloroquine toxicity. Ophthalmology 122:110\u2013116","journal-title":"Ophthalmology"},{"key":"9744_CR16","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.ajo.2006.12.042","volume":"143","author":"YS Lyons","year":"2007","unstructured":"Lyons YS, Severns ML (2007) Detection of early hydroxychloroquine retinal toxicity enhanced by ring ratio analysis of multifocal electroretinography. Am J Ophthalmol 143:801\u2013809","journal-title":"Am J Ophthalmol"},{"key":"9744_CR17","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1016\/j.ophtha.2015.02.011","volume":"122","author":"AC Tsang","year":"2015","unstructured":"Tsang AC, Ahmadi Pirshahid S, Virgili G et al (2015) Hydroxychloroquine and chloroquine retinopathy: a systematic review evaluating the multifocal electroretinogram as a screening test. Ophthalmology 122:1239\u20131251","journal-title":"Ophthalmology"},{"issue":"2","key":"9744_CR18","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.ophtha.2014.07.056","volume":"122","author":"C Cukras","year":"2015","unstructured":"Cukras C, Huynh N, Vitale S et al (2015) Subjective and objective screening tests for hydroxychloroquine toxicity. Ophthalmology 122(2):356\u2013366","journal-title":"Ophthalmology"},{"key":"9744_CR19","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1167\/iovs.17-22668","volume":"59","author":"AM Allahdina","year":"2018","unstructured":"Allahdina AM, Stetson PF, Vitale S et al (2018) Optical coherence tomography minimum intensity as an objective measure for the detection of hydroxychloroquine toxicity. Invest Ophthalmol Vis Sci 59:1953\u20131963","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"9744_CR20","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1136\/bjo.2008.157198","volume":"93","author":"S Kellner","year":"2009","unstructured":"Kellner S, Weinitz S, Kellner U (2009) Spectral domain optical coherence tomography detects early stages of chloroquine retinopathy similar to multifocal electroretinography, fundus autofluorescence and near-infrared autofluorescence. Br J Ophthalmol 93:1444\u20131447","journal-title":"Br J Ophthalmol"},{"key":"9744_CR21","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.2147\/OPTH.S14257","volume":"4","author":"E Chen","year":"2010","unstructured":"Chen E, Brown DM, Benz MS et al (2010) Spectral domain optical coherence tomography as an effective screening test for hydroxychloroquine retinopathy (the \u201cflying saucer\u201d sign). Clin Ophthalmol 4:1151\u20131158","journal-title":"Clin Ophthalmol"},{"key":"9744_CR22","first-page":"28","volume":"107","author":"KE Stepien","year":"2009","unstructured":"Stepien KE, Han DP, Schell J et al (2009) Spectral-domain optical coherence tomography and adaptive optics may detect hydroxychloroquine retinal toxicity before symptomatic vision loss. Trans Am Ophthalmol Soc 107:28\u201333","journal-title":"Trans Am Ophthalmol Soc"},{"key":"9744_CR23","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1001\/archopht.125.6.775","volume":"125","author":"JA Rodriguez-Padilla","year":"2007","unstructured":"Rodriguez-Padilla JA, Hedges TR, Monson B et al (2007) High-speed ultra-high-resolution optical coherence tomography findings in hydroxychloroquine retinopathy. Arch Ophthalmol 125:775\u2013780","journal-title":"Arch Ophthalmol"},{"key":"9744_CR24","first-page":"1158","volume":"17","author":"AR Rosenthal","year":"1978","unstructured":"Rosenthal AR, Kolb H, Bergsma D et al (1978) Chloroquine retinopathy in the rhesus monkey. Invest Ophthalmol Vis Sci 17:1158\u20131175","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"9744_CR25","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/j.1755-3768.1990.tb01892.x","volume":"68","author":"A Hallberg","year":"1990","unstructured":"Hallberg A, Naeser P, Andersson A (1990) Effects of long-term chloroquine exposure on the phospholipid metabolism in retina and pigment epithelium of the mouse. Acta Ophthalmol 68:125\u2013130","journal-title":"Acta Ophthalmol"},{"key":"9744_CR26","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s10633-018-9625-2","volume":"136","author":"C Arndt","year":"2018","unstructured":"Arndt C, Costantini M, Chiquet C et al (2018) Comparison between\u00a0multifocal\u00a0ERG\u00a0and C-Scan SD-OCT\u00a0(\u201cen face\u201d\u00a0OCT) in patients with a suspicion of antimalarial retinal toxicity: preliminary results. Doc Ophthalmol 136:97\u2013111","journal-title":"Doc Ophthalmol"},{"key":"9744_CR27","doi-asserted-by":"publisher","first-page":"251","DOI":"10.3928\/1542-8877-20030501-20","volume":"34","author":"SC So","year":"2003","unstructured":"So SC, Hedges TR, Schuman JS, Quireza ML (2003) Evaluation of hydroxychloroquine retinopathy with multifocal electroretinography. Ophthalmic Surg Lasers Imaging 34:251\u2013258","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"9744_CR28","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.ajo.2005.05.046","volume":"140","author":"TY Lai","year":"2005","unstructured":"Lai TY, Chan WM, Li H et al (2005) Multifocal electroretinographic changes in patients receiving hydroxychloroquine therapy. Am J Ophthalmol 140:794\u2013807","journal-title":"Am J Ophthalmol"},{"key":"9744_CR29","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1001\/jamaophthalmol.2014.3459","volume":"132","author":"RB Melles","year":"2014","unstructured":"Melles RB, Marmor MF (2014) The risk of toxic retinopathy in patients on long-term hydroxychloroquine therapy. JAMA Ophthalmol 132:1453\u20131460","journal-title":"JAMA Ophthalmol"},{"key":"9744_CR30","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1038\/eye.2016.298","volume":"31","author":"IH Yusuf","year":"2017","unstructured":"Yusuf IH, Sharma S, Luqmani R, Downes SM (2017) Hydroxychloroquine retinopathy. Eye 31:828\u2013845","journal-title":"Eye"},{"key":"9744_CR31","doi-asserted-by":"publisher","first-page":"179","DOI":"10.3109\/15569527.2014.938751","volume":"34","author":"P Agarwal","year":"2015","unstructured":"Agarwal P, Wong YH, Dasgupta E et al (2015) Early effect of hydroxychloroquine therapy: relationship between cumulative dose and retinal thickness. Cutan Ocul Toxicol 34:179\u2013184","journal-title":"Cutan Ocul Toxicol"},{"key":"9744_CR32","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1167\/iovs.02-0518","volume":"44","author":"W Seiple","year":"2003","unstructured":"Seiple W, Vajaranant TS, Szlyk JP et al (2003) Multifocal electroretinography as a function of age: the importance of normative values for older adults. Invest Ophthalmol Vis Sci 44:1783\u20131792","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"9744_CR33","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1001\/archopht.1995.01100030081025","volume":"113","author":"MR Hee","year":"1995","unstructured":"Hee MR, Izatt JA, Swanson EA et al (1995) Optical coherence tomography of the human retina. Arch Ophthalmol 113:325\u2013332","journal-title":"Arch Ophthalmol"},{"key":"9744_CR34","doi-asserted-by":"publisher","first-page":"e37638","DOI":"10.1371\/journal.pone.0037638","volume":"7","author":"A Mehreen","year":"2012","unstructured":"Mehreen A, Sumbul A, Kashif M, Mohammad IA (2012) Macular thickness by age and gender in healthy eyes using spectral domain optical coherence tomography. PLoS ONE 7:e37638. https:\/\/doi.org\/10.1371\/journal.pone.0037638","journal-title":"PLoS ONE"},{"key":"9744_CR35","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1001\/archopht.124.2.193","volume":"124","author":"A Chan","year":"2006","unstructured":"Chan A, Duker JS, Ko TH et al (2006) Normal macular thickness measurements in healthy eyes using stratus optical coherence tomography. Arch Ophthalmol 124:193\u2013198","journal-title":"Arch Ophthalmol"}],"container-title":["Documenta Ophthalmologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10633-019-09744-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10633-019-09744-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10633-019-09744-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,10]],"date-time":"2021-01-10T00:23:24Z","timestamp":1610238204000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10633-019-09744-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,11]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["9744"],"URL":"https:\/\/doi.org\/10.1007\/s10633-019-09744-0","relation":{},"ISSN":["0012-4486","1573-2622"],"issn-type":[{"type":"print","value":"0012-4486"},{"type":"electronic","value":"1573-2622"}],"subject":[],"published":{"date-parts":[[2020,1,11]]},"assertion":[{"value":"4 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Federica Bertoli, MD, was awarded a travel grant by the International Society for Clinical Electrophysiology of Vision to support her attendance at the 55th ISCEV international symposium, Miami, FL, October 2017, where she presented the preliminary results of this study. Maja \u0160u\u0161tar, PhD, declares that she has no conflict of interest. Martina Jarc Vidmar, MD, PhD, declares that she has no conflict of interest. Darko Perov\u0161ek, PhD, declares that he has no conflict of interest. Jelka Brecelj, PhD, declares that she has no conflict of interest. \u0160pela Markelj, MD, declares that she has no conflict of interest. Polona Jaki Mekjavi\u0107, MD, PhD, declares that she has no conflict of interest. Da\u0161a \u0160uput, MD, declares that she has no conflict of interest. Matija Tom\u0161i\u010d, MD, PhD, declares that he has no conflict of interest. Miriam Isola, PhD, declares that she has no conflict of interest. Claudio Battistella , MD, declares that he has no conflict of interest.\u00a0Paolo Lanzetta, MD, serves as a consultant for the following companies: Bayer, CenterVue, Novartis Pharma AG. Marko Hawlina, MD, PhD, declares that he has no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the Ethics Committee of the Medical Faculty, University of Ljubljana, Slovenia, and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. No animals were used in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights"}},{"value":"All procedures performed in this study were in accordance with the ethical standards of the Ethics Committee of the Medical Faculty, University of Ljubljana, Slovenia, and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}